Life Glow Plus
Super Life Glow
Life Glow Basic
Bone Dense Calcium
Taheebo Life Tea
Germanium
Colloidal Minerals
Methyl Sulfonyl Methane
Transfer Factor
Immune Egg

Vibrant Life Home Web
All VL Products
Family Of Three Chelation Formulas
Oral Chelation Ingredient Comparisons

The Wednesday Letter
Karl Loren Viewpoints
Frequently Asked Questions
Testimonials

Free Radicals
Central Page For 18 Web Sites
Vibrant Life Home Page

Shopping Cart

Separate Search Page
or search below


Navigation Help

Karl Loren Background

Ingredients Technical Write To Karl Loren Table Of Contents

Hidden Page

 

Karl Loren: My best guess is that the American Heart Association will quietly and suddenly deleted the page which contains the information shown below -- after their lies have been more widely exposed. You might want to check, for yourself. I found this page on their site as of February 22, 1997, but by December 14, 1997, it was no longer there.   Take my word for it, the AHA lied to us all and is now trying to cover up their lies.

INTERNATIONAL CARDIOVASCULAR DISEASE STATISTICS

Biostatistical Fact Sheet - Populations

INTERNATIONAL CARDIOVASCULAR DISEASE STATISTICS

Worldwide Cardiovascular Diseases Mortality

1990

Mortality is only a part of the overall burden created by cardiovascular disease. It may be that 25-30% of the cardiovascular disease burden arises from disabling sequelae of stroke or other forms of heart disease.

In 1990, in developed countries, 10.9 million deaths occurred. Just over 5.3 million deaths were attributed to cardiovascular disease, primary coronary heart disease (2.7 million) and stroke (1.4 million).

 

Significant declines are recorded for total cardiovascular disease mortality as well as specific cardiovascular diseases over the last few decades. Male mortality fell by over 60% in Japan, and by 50% or so in Australia, Canada, France and the United States. A similar pattern is seen for females.

Less impressive declines (20-25%) in cardiovascular disease mortality have been recorded for the Scandinavian countries, as well as Ireland, Portugal and Spain.

Cardiovascular disease death rates have risen by 40% in Hungary and the former Czechoslovakia, by almost 60% in Poland and by almost 80% in Bulgaria. These rates reflect massive increases in adult male mortality.

In both developed and developing countries, deaths from cardiovascular disease still account for almost 50% of all deaths.

In Africa, Western Asia and Southeast Asia, 15-20% of the estimated 20 million annual deaths are due to cardiovascular diseases. This translates to 3 to 4 million deaths, bringing the total for developing countries to 8 or 9 million, or about 70% more than that for developed countries.

 

EASTERN MEDITERRANEAN

(Bahrain, Cyprus, Egypt, Iran, Iraq, Jordan, Kuwait, Oman, Qatar and the United Arab Emirates)

Cardiovascular diseases are emerging as a major health problem in the Eastern Mediterranean Region. The proportion of deaths from cardiovascular disease ranges from 25 to 45%.

Coronary heart disease seems to be the predominant type of cardiopathy encountered in many countries, and hospital data indicate rising trends.

Several countries have experienced rapid socioeconomic changes over the last two decades. Daily caloric intake has increased. Among many Saudi Arabians aged 18 to 74 years, 51.5% of males and 65.4% of females were obese.

A high prevalence of smoking (>70%) has been reported among patients having acute myocardial infarction. Hypertension is found in 22-47% of cases and diabetes in over 30%.

High blood pressure (160/95) has been reported to have prevalence rates between 10% and over 17% of the adult population. The prevalence of hypertension appears to be increasing in parallel with affluence.

During 1986-90, 19 surveys were conducted in Egypt, Iraq, Pakistan and Sudan and over 400,000 schoolchildren were screened for rheumatic fever/rheumatic heart disease. A total of 1,807 cases were detected, representing a prevalence of 4.4 per 1,000. Sudan had the highest prevalence (10.2 per 1,000) and was followed by Egypt (5.1).

Rheumatic fever/rheumatic heart disease remains an important problem with children, adolescents and young adults in some countries. The World Health Organization is working with these countries to establish nationwide programs of prevention and control.

 

INDIA

A major tertiary care center reported a decline in the proportion of patients with rheumatic fever over a 30-year period, while the proportion with coronary heart disease rose from 4 to 33%. Similar trends were observed at the All India Institute of Medical Sciences.

The higher socioeconomic groups have a higher prevalence of coronary heart disease, indicating the initial phase of an epidemic.

High blood pressure (defined as 160/90 mmHg) ranges from 4.3 to 12.1%. In a survey in progress in urban Delhi, a prevalence of 17.4% has been observed in persons aged 35-64 years (using a threshold of 140/90 mmHg).

A national survey of children age 6-16 years revealed a prevalence rate of rheumatic heart disease of 5.3 per 1,000. Other studies including adults have led to estimates ranging from 1.4 to 2.2 per 1,000.

Surveys indicate about 950,000 annual deaths from cardiovascular diseases, but the true figure may be at least twice as large.

In China and India alone (accounting for about half the total population of the developing world), it may well be that some 4.5 to 5 million people die each year from cardiovascular disease.

 

SEYCHELLES

 

The Republic of Seychelles consists of 115 islands in the western Indian Ocean. Cardiovascular diseases account for 39% of mortality; hypertensive disease, coronary heart disease and stroke caused 8.4%, 8.0% and 5.9% of deaths respectively. A high prevalence of hypertension, cigarette smoking, serum total cholesterol, obesity, diabetes and lipoprotein (a) were found.

 

CHINA

The mortality rate attributable to cardiovascular disease increased from 86.2 per 100,000 in 1957 (12.1% of total deaths) to 214.3 per 100,000 in 1990 (35.8% of total deaths in urban areas).

The mortality rate attributable to cardiovascular disease has regularly been found to be higher in the north than in the south, i.e., the highest in Zhengzhou, Henan Province (50% for males and 63% for females) and the lowest in Zhanjiang, Guangdong Province, at 23% for both sexes.

Coronary heart disease is the leading cause of death in urban areas; pulmonary heart disease is the leading cause of death in rural areas.

The prevalence of hypertension is higher in the north than in the south. In 1979-80, the average prevalence rate for people age 15 and over, including borderline cases, was 7.73%, about 50% higher than in 1958-59 and still rising..

For adults, 61% of males and 7% of females are cigarette smokers.

Surveys conducted in Beijing in 1988-89 indicate 35.2% of men and 39.5% of women are overweight.

Blood cholesterol levels are uniformly low in comparison with values reported from Western countries.

Stroke has a high incidence and, in some areas, is the leading cause of death. The incidence of stroke is four times that of acute myocardial infarction, which, although it has been increasing in recent years, still has much lower incidence and mortality rates than those seen in most Western countries. Prevalence is currently about 5 million Chinese, 75% with varying degrees of incapacity. Incidence is 1.3 million new stroke patients per year.

There are 50-60 million hypertensive patients in China.

In China, data sources suggest that there are between 1 and 11/2 million stroke deaths a year, and about 600,000 additional deaths from all forms of heart disease. Altogether, cardiovascular disease probably claims something like 2.5 million lives -- or almost 30% of all deaths -- each year.

 

INDONESIA

Cardiovascular disease has become the leading cause of death, accounting for 16.5% of all mortality.

The cardiovascular mortality rate is 5.5 per 100,000 people aged 15-24 and 943.5 per 100,000 for people aged 55+.

The prevalence of cardiovascular disease was estimated at 508.3 per 100,000 population. High blood pressure was the most prevalent at 416.3 per 100,000 population and ischemic heart disease was 73 per 100,000 population.

59.9% of men and 5.9% of women in Indonesia are smokers.

Hypertension was detected in 13.6% of men and 16% of women.

Of the people with hypertension, 56.1% were aware of the condition; 50.9% were being treated but only 10% were receiving adequate treatment.

Mean serum cholesterol levels were 199.9 mg/dl in men and 206.6 mg/dl in women. Compared to levels in Western countries, these values are low, but are considered high relative to the Japanese figure of 190 mg/dl.

Obesity was found in only 12.5% of respondents.

 

AFRICA

Tobacco cultivation occupies up to 72% of arable land in some developing countries. Zimbabwe derives most of its foreign exchange from this source.

Cigarette consumption in Africa has increased by over 40% in the past two decades.

Cardiovascular mortality ranges from 20 to 45%.

Obesity ranges from 8.3% for men to 35.7-50% for women.

Over half the patients with either hemorrhagic or nonembolic stroke have been shown to be hypertensive.

High blood pressure at frequencies exceeding 5-10% in most rural areas and 12% in most urban areas, together with complications such as stroke, heart failure and renal failure, are leading causes of morbidity and mortality.

Rheumatic heart disease and its complications constitute the second most important cardiovascular entity resulting in hospital admissions. Rheumatic heart disease accounts for about 30% of cardiovascular hospital admissions.

Among schoolchildren the prevalence of rheumatic heart disease ranges from less than one percent to 15% per 1,000.

Cardiomyopathies of unknown origin are estimated to make up 5-20% of cardiovascular disorders in various regions.

Frequencies of coronary heart disease are relatively low but the situation is rapidly changing. Coronary heart disease appears to be more common in northern African countries. Prognosis is considerably worse in black women than in black men.

Over 60% of the population of most African countries consists of youths less than 15 years of age. On the Ivory Coast, Congenital disorders represent about 12% of hospital admissions behind hypertension (39%) and rheumatic heart disease (14%).

Over 15% of cardiovascular admissions in some hospitals may relate to primary pericardial disease.

Infective endocarditis may be more common than formerly suspected, as suggested by the prevalence of valvular disorders of rheumatic origin and unrecognized congenital cardiac lesions. Rates of infective endocarditis ranging from less than 2% to over 10% have been reported among patients hospitalized for various cardiovascular disorders.

Atherosclerosis and peripheral vascular disease conditions are rare in Africans, although this is changing rapidly because of shifts in aging patterns and more urbanized lifestyles, which affect other risk factors.

THE AMERICAS

Cardiovascular disease is the leading cause of death in 31 of 35 countries reporting mortality statistics.

The highest total cardiovascular disease mortality rates for both males and females were in the English-speaking Caribbean, North American and Southern Cone sub regions (Argentina, Chile and Uruguay). The lowest were in the Latin Caribbean and Central America. Countries of the Andean sub region had intermediate levels.

All selected countries showed a declining trend for both males and females with the exception of Guatemala, El Salvador, and the Dominican Republic, which are still experiencing an increase.

The highest rates of ischemic heart disease were in Argentina, Canada , the United States, Trinidad and Tobago, and Uruguay. The lowest were found initially in Barbados, the Dominican Republic, Mexico and Central America. In the latter group, the rates are still increasing for both sexes.

Looking at data for two three-year periods around 1969 and 1986 respectively, the highest stroke mortality rates were found in the English-speaking Caribbean and the Southern Cone sub regions. The lowest rates were found in Guatemala for males and initially for females. In recent years, female rates in Guatemala increased; males rates in Colombia and rates for both sexes increased in the Dominican Republic and El Salvador. Canada and the United States had the lowest mortality rates for females and one of the lowest for males in the second period; these countries also showed the greatest declines.

Mortality rates attributed to hypertensive disease have declined markedly except in Guatemala, Mexico, and Venezuela. Costa Rica and the Dominican Republic have experienced an increase only among males. Declines have been slightly higher for females, most notably in Argentina, Chile, Canada, the United States, and Trinidad and Tobago.

Mortality rates for rheumatic fever/chronic rheumatic heart disease underwent a larger decline than rates for coronary heart disease, stroke, total cardiovascular disease and high blood pressure. However, rheumatic fever/rheumatic heart disease are still regarded as major causes of morbidity and utilization of health care services.

In Latin America, data indicate approximately 800,000 CVD deaths a year. This represents about 25% of all deaths, with roughly as many males as females dying from cardiovascular disease.

Source - World Health Organization, World Health Statistics Quarterly, Vol. 46, No. 2, 1993.

----------------------------------------------------------------------

Copyright © 1996 American Heart Association


Special Pages On The Various of Web Sites Authored by Karl Loren
OC History Oral Chelation Testimonials
Family Of Three Oral Chelation Formulas Life Glow Basic Life Glow Basic Ingredient List
Life Glow Plus Life Glow Plus
Ingredient List
American Heart Association -- Lies
Super Life Glow Super Life Glow
 Ingredient List
FAQ
All Products Shopping Cart Order Section Research
Taheebo Life Tea Witch Doctors Versus Harvard MSM Sulfur
Calcium How Bones Grow Colloidal Minerals
Jean Ross Philosophy The Wednesday Letter
Arthritis & James Coburn's Use Of MSM Karl Loren Viewpoints News And Announcements
Dr. Flanagan's Microhydrin 500 Page Book On Heart Disease Colostrum & Transfer Factor
Germanium Ultrasound Technology Bulk MSM
Cancer & Biopsy Diabetes Heart Disease & Bypass Surgery
Karl Loren's Diet Guarantee Navigation Help Page
The Links Below Jump To Pages On Whatever Web You Are In
Table Of Contents Search This Web Navigation Help Page
Write To Karl Loren -- He Pledges To Answer EVERY Personal Message, Personally.  Click here or on his name in the box below.
The Links Below Are To Various Web Sites Published By Karl Loren
Karl Loren Web Vibrant Life Web Karl Loren's Book
Super Colostrum Bulk MSM Heart Disease
Emmessar Happiness Arthritis
Instead Of Chelation Therapy Super Colostrum (2)
Immune Egg Central Page For All Web Sites!
 

I promise to answer your message -- click here to send me a personal message

Dear Karl,                                        

 

 

 

 

SUBSCRIBE:  The Wednesday Letter is a free electronic monthly newsletter written and published by Karl Loren.  You can view more than 50 back issues of this publication by clicking here.  The Wednesday Letter subscription list is maintained on a secure server, no name is ever given or sold to anyone, and it is never used except for this Newsletter.  It is automatically published on the Tuesday night just before the first Wednesday of every month.  You can subscribe to this free monthly electronic letter by entering your eMail address and name below.  You will then automatically receive a request for confirmation, sent to whatever address you have entered.  If you do NOT receive this confirmation request, then you will not be subscribed.  There may have been an error with your address and you should resubmit.  The letter is never sent twice to the same address -- so you do not have to worry about a duplicate subscription.  When you receive this confirmation request you must reply to it, or your subscription will not become active.  No one can subscribe your name, and address, without you being notified, and if you get an unwanted notice of subscription you only need to DO NOTHING and the subscription will NOT be active.

E-Mail Address:
First Name:
Last Name:

REMOVAL:  You can remove yourself from the subscription list in several different ways.  Click here to read about this entire newsletter system.  Every edition of The Wednesday Letter is delivered to your address with YOUR name and address in view on the letter, with a link that allows you to remove THAT name from the subscription list.  If you try to send this removal message from an address different from the one you used to send in your original confirmation, then you will get a warning notice first, sent to the subscription address, asking you to confirm that you want to be removed from the list -- by replying to THAT request for confirmation, you will then be automatically removed.  Thus, no one else can unsubscribe you, from some other computer, without your knowledge.  But, if you send in the unsubscribe notice from the same machine used to receive the Letter, then the removal from the subscription list is automatic.

E-Mail Address:

Personal Message:  When you send a personal message to Karl Loren, you will receive a personal reply as per his instructions.  Karl pledges that every personal message will get a personal answer. When you provide your mail address, we will send you free information including our free catalog and a cassette tape lecture by Karl Loren about heart disease, no charge, by mail, even if outside the US.  You can select particular information you would like to receive, along with the free cassette tape and catalog.

You can reach Vibrant Life in many ways, including by mail to Vibrant Life, 2808 N. Naomi St., Burbank, CA 91504.  Within the US and Canada, use the toll free number:  (800) 523-4521, the local number:  (818) 558-1799, the FAX:  (818) 558-7299, eMail to kimberly@oralchelation.com or any one of the hundreds of message forms throughout the 50 web sites.  Vibrant Life normally ships the same day we get an order.  There are message forms on each of the 100,000+ pages on this and other sites where you can communicate with Vibrant Life.  Check out our companion site, at:  http://www.oralchelation.net where Karl's 2000 page book is published.  Karl Loren is the author and webmaster for this BOOK, as well as for another web site about ORAL CHELATION.  His personal philosophical articles are at PHILOSOPHY

Copyright © April 25, 2008 2:38 AM by Karl Loren on behalf of Vibrant Life, ALL RIGHTS RESERVED.  Permission is granted for non-commercial downloading, copying, distribution or redistribution on two conditions:  One, that some form of copyright notice is included in every copy distributed or copied, showing the copyright belonging to Vibrant Life, Burbank, CA, at www.oralchelation.com . The second condition is that the material is not to be used for any purpose contrary to the purposes and objectives of this site.  This permission does not extend to materials on this site which are copyrighted by others.